![Yi Pin Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Pin Huang
Directeur/Membre du Conseil chez
PHARMADAX INC.
Profil
Yi Pin Huang is the founder of PharmaDax Inc. since 2008, holding the title of Director.
Mr. Huang's current jobs include Chairman at PharmaDax USA, Inc., Chairman at PharmaDax (Hong Kong) Ltd., Chairman at Ansbach Acoustic International Ltd., Director at Reach High Enterprises Ltd., Director at Master Brand Global Corp., Director at Quantex Holding Ltd., and Member-Supervisory Board at Shengqun Pharmaceutical Co., Ltd. Education history includes a graduate degree from St. John's University and an undergraduate degree from Taipei Medical University.
Postes actifs de Yi Pin Huang
| Sociétés | Poste | Début |
|---|---|---|
| PHARMADAX INC. | Directeur/Membre du Conseil | - |
PharmaDax USA, Inc.
 PharmaDax USA, Inc. Pharmaceuticals: MajorHealth Technology The company is located in the US. Part of PharmaDax Inc., PharmaDax USA, Inc. is an American pharmaceutical company specializing in the development, manufacturing, and commercialization of modified-release generic drugs, particularly in the central nervous system and cardiovascular system therapeutic areas. The company develops advanced modified-release oral solid dosage forms, including non-erosive adjustable drug delivery systems, modified-release orally disintegrating tablets, sustained-release gastro-retentive forms, and transdermal patches. PharmaDax USA provides services such as co-development, marketing partnerships, dossier development, technology transfer, and contract manufacturing for regulated markets. | Président | - |
PharmaDax (Hong Kong) Ltd. | Président | - |
Reach High Enterprises Ltd. | Directeur/Membre du Conseil | - |
Master Brand Global Corp. | Directeur/Membre du Conseil | - |
Quantex Holding Ltd. | Directeur/Membre du Conseil | - |
Ansbach Acoustic International Ltd. | Président | - |
Shengqun Pharmaceutical Co., Ltd. | Directeur/Membre du Conseil | - |
Formation de Yi Pin Huang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taipei Medical University
 Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Health Technology |
PharmaDax USA, Inc.
PharmaDax USA, Inc. Pharmaceuticals: MajorHealth Technology The company is located in the US. Part of PharmaDax Inc., PharmaDax USA, Inc. is an American pharmaceutical company specializing in the development, manufacturing, and commercialization of modified-release generic drugs, particularly in the central nervous system and cardiovascular system therapeutic areas. The company develops advanced modified-release oral solid dosage forms, including non-erosive adjustable drug delivery systems, modified-release orally disintegrating tablets, sustained-release gastro-retentive forms, and transdermal patches. PharmaDax USA provides services such as co-development, marketing partnerships, dossier development, technology transfer, and contract manufacturing for regulated markets. | Health Technology |
PharmaDax (Hong Kong) Ltd. | |
Reach High Enterprises Ltd. | |
Master Brand Global Corp. | |
Quantex Holding Ltd. | |
Ansbach Acoustic International Ltd. | |
Shengqun Pharmaceutical Co., Ltd. |
